The 2027 Compliance Calendar: Five Clocks and Event-Driven Duties

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Sorting the post-licence obligations of Nigerian certificate holders by time character yields five clocks:

ClockPeriodLegal basis
Registration certificate renewal5 yearsRegulation 4(7), §11.2/§12.2
Advertisement permitFirst grant 1 year / renewal without change 2 years / promotional 15 weeksRegulation 32
Compliance query response90 days (VBM-R&RA-GDL-001-01 §11.6) / 90 working days (R&R-GDL-008-02 §12.6) → automatic closure§11.6/§12.6
Complaint record retentionNot less than 1 year beyond the shelf life, or 1 year after complaint resolution, whichever is longerDER-GDL-025-00 §13.1(f)
Mock recallAnnual (the guideline sets no specific frequency; executed annually)DER-GDL-025-00 §13.2

There are also three event-driven obligations (no fixed period): change notification or prior approval (Regulation 6), vigilance and adverse event reporting (Regulations 12(3)(4)), and disposal of expired, degraded or obsolete devices (Regulation 13).

2. Legal basis

InstrumentReference numberDateProvisions
NAFDAC Medical Devices and Related Products (Registration, Labelling and Advertisement) Regulations, 2024S.I. No. 42 of 202416 October 2024Regulation 4(7) (5 years), Regulation 6 (changes), Regulation 11 (storage and distribution), Regulation 12 (PMS and vigilance), Regulation 13 (disposal), Regulation 32 (advertisement validity)
NAFDAC Medical Devices GMP Guidelines 2024DER-GDL-025-00Effective 11 November 2024§13.1(f) (complaint record retention), §13.2 (recalls and mock recalls)
NAFDAC Recall of Defective Medical ProductsPMS-GDL-020-00Effective 30 September 2024§4–§6 (classification, communication, progress monitoring)
NAFDAC Guidelines for Registration of Medical Devices Including In Vitro Diagnostics (IVDs) and Related ProductsVBM-R&RA-GDL-001-01Effective 10 April 2025§11.2, §11.5, §11.6, §11.7, §11.8
NAFDAC Regulatory Directive on Regulatory RelianceNAFDAC-RDRR-005-04Effective 11 October 2025 (review 10 October 2030)§2.1, §3.1.4, §3.1.5

3. Expert insights

Insight 1: what Nigerian certificate holders lose control of most easily is not a big obligation but two sets of clocks out of sync.

The registration certificate runs 5 years; advertisement permits run 1 year / 2 years / 15 weeks — two clocks that do not align, and renewal of the advertisement permit is conditional on no change of content. A single 5-year registration certificate requires at least 4 advertisement permit renewals within its life (1 + 2 + 2, with promotional materials counted separately at 15 weeks). This is the structural gap flagged already in article 30.

Insight 2: the 90 days for compliance queries is a red line for application survival, not a suggested response time.

§11.6 (90 days) / §12.6 (90 working days): without a reply within the period, the application closes automatically. And issuing the compliance query stops the clock (§11.8/§12.8). This means your delay consumes none of the official review time, but it consumes the life of your own application.

Insight 3: PMS and vigilance are continuing obligations with no expiry date, but they will be inspected.

The PMS system of Regulation 12(2) (monitoring, collection, evaluation, response) and the vigilance obligation of Regulation 12(3) run through the entire validity of the registration. Their value lies not in how many reports were filed but in being able to demonstrate that the system is running — quarterly trend evaluation reports are the best evidence.

Insight 4: the biggest variable for 2026–2027 is whether the 2025 draft is gazetted.

If the draft (published 23 July 2025, comment period until 20 September 2025) is gazetted, it will introduce clinical investigation (§3–§16), manufacturing quality systems (§17–§31), establishment registration (§46), reprocessing of single-use devices (§44), refurbishment (§45) and other systems. Reserve one quarter in the 2027 plan for transitional preparation after gazettal.

Insight 5: turning the verification checklist into a ledger is the only way this system lands.

Each of the 50 articles in this series ends with a verification checklist. They are not reading aids but internal audit sheets. Reorganize them into a single annual ledger built around the five clocks plus the three event-driven obligations, and roll it forward month by month.

4. Practical recommendations

  1. Build one master ledger for the five clocks: registration certificate, advertisement permit, compliance queries, record retention, mock recall — each with alert milestones.
  2. Start the renewal self-check 12 months before registration expiry, covering changes, compliance queries, PMS and vigilance, and label consistency.
  3. Alert 90 days before advertisement permit expiry, and compare the renewal text word for word with the approved version (Regulation 33).
  4. Set the internal response deadline for compliance queries at 30 days, far ahead of the 90 days / 90 working days red line.
  5. Produce quarterly PMS and vigilance trend evaluation reports, and trigger the corresponding actions.
  6. Schedule the mock recall as an annual project (§13.2), verifying batch traceability.
  7. Reserve one quarter of transition preparation for the gazettal of the 2025 draft.
  8. Confirm all fees case by case as a practical estimate; the official fee schedule follows the current NAFDAC Tariff.

5. Verification checklist

  • □ Registration certificate renewal milestone set (5 years, self-check starts 12 months early).
  • □ Advertisement permit milestones set (1 year / 2 years / 15 weeks, alert 90 days early).
  • □ Internal deadline for compliance query response set at 30 days.
  • □ Complaint record retention complies with §13.1(f) (at least 1 year beyond shelf life, or at least 1 year after complaint resolution, whichever is longer).
  • □ Mock recall included in the annual plan (§13.2).
  • □ Change notification ledger established (Regulation 6).
  • □ Reporting channels and deadlines for vigilance and adverse events implemented (Regulations 12(3)(4)).
  • □ Contingency plan for disposal of expired, degraded or obsolete devices prepared (Regulation 13).
  • □ Tracking mechanism for gazettal of the 2025 draft running and transition period reserved.
  • □ All fees confirmed case by case as a practical estimate.

Regulatory information verified as of 29 October 2026. All content cited in this document has been checked against the official NAFDAC regulation text (S.I. No. 42 of 2024, Regulations 4(7), 6, 11, 12, 13, 32 and 33), the GMP guidelines (DER-GDL-025-00 §13.1(f) and §13.2, effective 11 November 2024), the recall guideline (PMS-GDL-020-00, effective 30 September 2024), VBM-R&RA-GDL-001-01 (§11.2, §11.5–§11.8, effective 10 April 2025) and NAFDAC-RDRR-005-04 (effective 11 October 2025); the 2025 draft has not yet been gazetted and is provided for regulatory direction only; fees are treated as a practical estimate.

  • Local Nigeria resources: GRZAN can coordinate locally licensed import entities and authorized representative resources, covering NAPAMS online submission, dossier screening clearance interfacing, import permits, sample delivery and laboratory analysis support.
  • Service capability: classification determination, registration pathway selection, technical documentation (IMDRF ToC) drafting, CMFS and notarization/legalization, GMP and foreign inspection preparation, advertisement permits, vigilance and PMS reporting, change management and renewal.
  • Contact: info@grzanglobal.com; website www.grzan.cn.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail